insufficient data
| T vs. C | placebo plus SoC | atezolizumab plus nab-paclitxel followed by doxorubicin plus cyclophosphamide |
| placebo plus SoC | --- | NA |
| atezolizumab plus nab-paclitxel followed by doxorubicin plus cyclophosphamide | NA | --- |
pathologies: 306
- treatments: 1282
result logic
